Croatian tennis player Marin Cilic has reportedly denied allegations by the International Tennis Federation (ITF) that he had pulled out of this year's Wimbledon Championships by faking a knee injury to disguise a failed drug test.
Cilic was banned for nine months for testing positive for banned supplement nikethamide after taking Coramine glucose tablets purchased at a pharmacy in Monte Carlo.
Stating that he wanted to address 'certain media reports' which suggested that he had 'feigned' an injury at Wimbledon, Cilic said that he had already developed a significant knee injury before Wimbledon, which got aggravated during his first round match.
However, Cilic insisted that although he was very keen to continue playing at Wimbledon, he was advised that there was a possibility that his Wimbledon results could be wiped out depending on the result of his case.
According to Cilic, it did not make any sense for him to risk causing his knee a more severe injury and to deprive other players the opportunity of playing further into the tournament, following which he decided to pull out of Wimbledon and accept a voluntary suspension pending the determination of his case.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
